A detailed history of Resonant Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 26,287 shares of JNJ stock, worth $4.4 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
26,287
Previous 25,931 1.37%
Holding current value
$4.4 Million
Previous $4.2 Million 9.54%
% of portfolio
0.28%
Previous 0.31%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$143.34 - $165.86 $51,029 - $59,046
356 Added 1.37%
26,287 $3.8 Million
Q3 2024

Oct 18, 2024

BUY
$145.48 - $167.38 $105,909 - $121,852
728 Added 2.89%
25,931 $4.2 Million
Q2 2024

Aug 01, 2024

SELL
$144.38 - $157.78 $160,983 - $175,924
-1,115 Reduced 4.24%
25,203 $3.68 Million
Q1 2024

May 01, 2024

BUY
$155.22 - $162.74 $204,735 - $214,654
1,319 Added 5.28%
26,318 $4.16 Million
Q4 2023

Jan 31, 2024

SELL
$145.6 - $158.88 $260,478 - $284,236
-1,789 Reduced 6.68%
24,999 $3.92 Million
Q3 2023

Oct 31, 2023

BUY
$155.75 - $174.48 $325,517 - $364,663
2,090 Added 8.46%
26,788 $4.17 Million
Q2 2023

Jul 25, 2023

BUY
$154.35 - $166.11 $329,382 - $354,478
2,134 Added 9.46%
24,698 $4.09 Million
Q1 2023

Apr 21, 2023

SELL
$151.05 - $180.26 $272,645 - $325,369
-1,805 Reduced 7.41%
22,564 $3.5 Million
Q4 2022

Jan 23, 2023

BUY
$160.2 - $179.79 $187,594 - $210,534
1,171 Added 5.05%
24,369 $0
Q3 2022

Oct 20, 2022

BUY
$161.33 - $179.52 $85,827 - $95,504
532 Added 2.35%
23,198 $3.79 Million
Q2 2022

Jul 12, 2022

BUY
$168.19 - $186.01 $29,769 - $32,923
177 Added 0.79%
22,666 $4.02 Million
Q1 2022

Apr 19, 2022

BUY
$158.14 - $179.59 $251,442 - $285,548
1,590 Added 7.61%
22,489 $4.01 Million
Q4 2021

Jan 26, 2022

BUY
$155.93 - $173.01 $506,928 - $562,455
3,251 Added 18.42%
20,899 $3.58 Million
Q3 2021

Oct 18, 2021

BUY
$161.5 - $179.47 $311,856 - $346,556
1,931 Added 12.29%
17,648 $2.85 Million
Q2 2021

Jul 16, 2021

BUY
$159.48 - $171.07 $54,063 - $57,992
339 Added 2.2%
15,717 $2.59 Million
Q1 2021

Apr 28, 2021

BUY
$153.07 - $170.48 $190,112 - $211,736
1,242 Added 8.79%
15,378 $2.53 Million
Q4 2020

Jan 15, 2021

BUY
$137.11 - $157.38 $85,830 - $98,519
626 Added 4.63%
14,136 $2.23 Million
Q3 2020

Nov 03, 2020

SELL
$140.38 - $153.83 $63,030 - $69,069
-449 Reduced 3.22%
13,510 $2.01 Million
Q2 2020

Aug 05, 2020

SELL
$128.81 - $155.51 $542,290 - $654,697
-4,210 Reduced 23.17%
13,959 $1.96 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $113,807 - $157,685
1,024 Added 5.97%
18,169 $2.38 Million
Q4 2019

Feb 18, 2020

BUY
$127.5 - $146.44 $2.19 Million - $2.51 Million
17,145 New
17,145 $2.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $437B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Resonant Capital Advisors, LLC Portfolio

Follow Resonant Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.